Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

TRYP Therapeutics

18 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Receptor Pharmacology 12 Pharmacology 12 Depression 7 Clinical Trial 6 Safety 5 Addiction 5 Anxiety 4 Animal Study 3 Toxicity 3 Chronic Pain 2 Healthcare Workers 2 Mechanism of Action 2

Journals

Journal of Pharmacology and Experimental Therapeutics 6 ClinicalTrials.gov 4 Clinical Pharmacology & Therapeutics 4 Neurotherapeutics 2 American Journal of Therapeutics 1 CNS Neuroscience & Therapeutics 1

Publication history

Prohedonic Effects of Psilocybin (COMP360) in a Touchscreen-Based Rodent Probabilistic Reward Task (Abstract ID: 227883)Journal of Pharmacology and Experimental Therapeutics · 2026-04-30 PDE4B Inhibition and Psilocybin as Promising Approaches for Treating Methamphetamine Use Disorder: Preclinical Evidence From Rat Models (Abstract ID: 232554)Journal of Pharmacology and Experimental Therapeutics · 2026-04-30 Effects of Psilocybin on Attentional Set-Shifting Following Chronic Unpredictable Stress in Rats (Abstract ID: 231339)Journal of Pharmacology and Experimental Therapeutics · 2026-04-30 A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Oral Psilocybin (TRP-8802) Administration in Concert With Psychotherapy Among Adult Patients With Irritable Bowel Syndrome: A Randomized Delayed Treatment Control DesignClinicalTrials.gov · 2026-02-04 Single-dose psilocybin promotes cell-type-specific changes of neurons in the orbitofrontal cortexNeurotherapeutics · 2025-12-31 Evaluating the Influence of CYP450 Enzyme Inducers on the Efficacy of Psilocybin as a Treatment for Neuropsychiatric Disorders (Abstract ID: 167358)Journal of Pharmacology and Experimental Therapeutics · 2025-02-28 A Phase 2a Safety and Feasibility Study Evaluating Psilocybin (TRP-8802) Administration in Concert With Psychotherapy in the Treatment of Binge Eating DisorderClinicalTrials.gov · 2024-11-18 A24-Week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Clinical Trial to Evaluate Efficacy and Safety of Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)ClinicalTrials.gov · 2024-08-14 The Classical Psychedelic Psilocybin Mitigates Oxycodone WithdrawalJournal of Pharmacology and Experimental Therapeutics · 2024-05-12 Psilocybin-induced anxiolytic effects supported by transient elevation of corticosteroneJournal of Pharmacology and Experimental Therapeutics · 2024-05-12 Psychedelic Therapy: A Primer for Primary Care Clinicians-PsilocybinAmerican Journal of Therapeutics · 2024-02-29 Evaluating the Effect of Length of Time on Selective Serotonin Reuptake Inhibitors (SSRIs) on the Response to Psilocybin-assisted Therapy in Individuals With Mild-moderate Major Depressive Disorder (MDD)ClinicalTrials.gov · 2023-07-05 Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signalingCNS Neuroscience & Therapeutics · 2023-01-09 Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy ParticipantsClinical Pharmacology & Therapeutics · 2022-12-11 Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects.Clinical Pharmacology & Therapeutics · 2021-11-21 Exploratory Controlled Study of the Migraine-Suppressing Effects of PsilocybinNeurotherapeutics · 2020-11-11 Psychedelic Drugs as Therapeutics: No Illusions About the Challenges.Clinical Pharmacology & Therapeutics · 2017-08-23 Psilocybin: Good Trip or Bad Trip.Clinical Pharmacology & Therapeutics · 2017-05-25

Author directory